Clinical Trials Browser

Phase 1 × Unknown × MART-1 Antigen × Clear all

NCT00037037 2013-12-18

Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma

Phase 1 Unknown

Melanoma